- Home
- ALNY vs FLUT Comparison
ALNY vs FLUT Comparison
Compare ALNY & FLUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- FLUT
- Stock Information
- Founded
- ALNY 2002
- FLUT 2016
- Country
- ALNY United States
- FLUT United States
- Employees
- ALNY N/A
- FLUT N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- FLUT
- Sector
- ALNY Health Care
- FLUT
- Exchange
- ALNY Nasdaq
- FLUT NYSE
- Market Cap
- ALNY 39.6B
- FLUT 40.2B
- IPO Year
- ALNY 2004
- FLUT N/A
- Fundamental
- Price
- ALNY $309.70
- FLUT $263.89
- Analyst Decision
- ALNY Strong Buy
- FLUT Strong Buy
- Analyst Count
- ALNY 25
- FLUT 19
- Target Price
- ALNY $324.96
- FLUT $304.68
- AVG Volume (30 Days)
- ALNY 849.2K
- FLUT 2.3M
- Earning Date
- ALNY 07-31-2025
- FLUT 08-07-2025
- Dividend Yield
- ALNY N/A
- FLUT N/A
- EPS Growth
- ALNY N/A
- FLUT N/A
- EPS
- ALNY N/A
- FLUT 2.89
- Revenue
- ALNY $2,348,099,000.00
- FLUT $14,316,000,000.00
- Revenue This Year
- ALNY $30.77
- FLUT $22.76
- Revenue Next Year
- ALNY $30.51
- FLUT $15.90
- P/E Ratio
- ALNY N/A
- FLUT $92.49
- Revenue Growth
- ALNY 17.21
- FLUT 16.68
- 52 Week Low
- ALNY $153.23
- FLUT $175.59
- 52 Week High
- ALNY $317.54
- FLUT $299.73
- Technical
- Relative Strength Index (RSI)
- ALNY 63.60
- FLUT 57.27
- Support Level
- ALNY $295.82
- FLUT $263.19
- Resistance Level
- ALNY $317.54
- FLUT $276.45
- Average True Range (ATR)
- ALNY 7.74
- FLUT 6.08
- MACD
- ALNY -0.67
- FLUT 1.03
- Stochastic Oscillator
- ALNY 63.90
- FLUT 63.48
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About FLUT FLUTTER ENTERTAINMENT PLC
In 2016, Irish company Paddy Power merged with UK firm Betfair to form online gaming operator Flutter Entertainment. Today, Flutter has the top digital revenue share in the US, UK and Ireland, Australia, and many other countries. Some of its main brands are FanDuel in the US, Sky Betting & Gaming and Paddy Power in the UK and Ireland, Sportsbet (acquired by Paddy Power in 2009) in Australia, and Sisal in Italy. As of Dec. 31, 2024, the company offered products in over 100 countries and had 13.9 million average monthly users. In 2024, sports betting was 56% of revenue, online gaming 40%, and fantasy sports, horse racing, and other 4%.